- Title
- Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients
- Creators
- Adam Weizman - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USABrian Huang - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADror Berel - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAStephan R Targan - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAMarla Dubinsky - Departments of Pediatrics, Pediatric Inflammatory Bowel Disease Center, Cedars Sinai Medical Center, Los Angeles, California, USAPhillip Fleshner - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAAndrew Ippoliti - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAManreet Kaur - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADeepa Panikkath - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USASteve Brant - Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, School of Medicine, and Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USAIoannis Oikonomou - Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USARick Duerr - Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USAJohn Rioux - Universite de Montreal and the Montreal Heart Institute, Research Center, Montreal, Quebec, CanadaMark Silverberg - Mount Sinai Inflammatory Bowel Disease Center, University of Toronto, Toronto, Ontario, CanadaJerome I Rotter - Institute for Translational Genomics and Population Sciences, Los Angeles BioMedical Research Institute and Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California, USAEric Vasiliauskas - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USATalin Haritunians - Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADavid Shih - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADalin Li - Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USAGil Y Melmed - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADermot P.B McGovern - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- Publication Details
- Inflammatory bowel diseases, Vol.20(3), pp.525-533
- Date published
- 03/2014
- Academic Unit
- Medicine - Gastroenterology and Hepatology (RWJMS)
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031665448804646
Journal article
Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients
Inflammatory bowel diseases, Vol.20(3), pp.525-533
03/2014
PMCID: PMC4046633
PMID: 24487271
Metrics
12 Record Views